TSEN2 mutations, although infrequent, result in PCH2B characterized by common neurological findings including microcephaly, developmental delay, intellectual disability, epilepsy, dyskinesia, central visual impairment, and hyperkinetic involuntary movements [7, 32]. The gene discussed is TSEN2; the disease is drug-induced dyskinesia.